Hepatitis C Home > Sovaldi and Breastfeeding
The manufacturer of Sovaldi (sofosbuvir) recommends that women either avoid breastfeeding during treatment or not receive the drug. Although no studies have been done to determine if Sovaldi passes through breast milk or if it would harm a nursing infant, potentially dangerous side effects are possible, which may pose a risk to a baby whose mother uses the drug while nursing.
Sovaldi™ (sofosbuvir) is a prescription medicine used to treat chronic hepatitis C. At this time, it is not known if Sovaldi passes through breast milk in humans. The manufacturer of Sovaldi recommends women choose either breastfeeding or Sovaldi treatment. Therefore, if you are breastfeeding, talk with your healthcare provider before taking Sovaldi.
No studies have been done to see if Sovaldi passes through breast milk in humans. In animal studies, Sovaldi was shown to pass through the breast milk of rats, without causing any problems in the baby rats.
Although it is unclear whether a nursing infant would be exposed to the medication, because of the potential for serious side effects, the manufacturer recommends that the medicine not be used while breastfeeding. However, if you and your healthcare provider decide that you should breastfeed while taking this medication, be sure to watch for any problems or unexpected changes in your infant.
You should discuss breastfeeding and Sovaldi use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.